Sökning: "MHC class I molecules"
Visar resultat 16 - 20 av 102 avhandlingar innehållade orden MHC class I molecules.
16. Influence of MHC class I peptide interaction on antigen presentation in normal and malignant cells
Sammanfattning : The presentation of MHC class I peptide complexes in normal and malignant cells was studied. An HLA A11 binding motif was defined by comparing synthetic peptide analogues of a known cytotoxic T Iymphocyte (CTL) target epitope for induction of surface A11 expression and triggering of cytotoxic activity. LÄS MER
17. MHC and genomic diversity in Atlantic salmon (Salmo salar L.)
Sammanfattning : In this thesis I present studies concerning genomic diversity and genetic heterogeneity as well as the evolution and maintenance of genetic variation at a specific immune defence gene in Atlantic salmon (Salmo salar, L.). LÄS MER
18. Mapping of the specificity in MHC class I recognition by natural killer cells
Sammanfattning : Natural killer (NK) cells represent the third major lymphocyte subpopulation. They are distinguishable from B and T lymphocytes by their surface phenotype, cytokine profile and the ability to mediate spontaneous cytotoxicity, without prior sensitization, against certain tumor cells and virally infected cells. LÄS MER
19. MHC-class I restricted peptide-based immunomodulation of CD8+ T and NK cells
Sammanfattning : The main aims of the immune system are to protect the host from potential threats by distinguishing self from non-self and altered-self. T cells and NK cells play a key role in the identification and elimination of threats by scanning a repertoire of peptide epitopes presented by major histocompatibility complex (MHC) molecules. LÄS MER
20. Decoding NK cell receptor specificity : functional and structural studies of MHC class 1 subcomponents
Sammanfattning : Natural Killer (NK) cells are an important part of the innate immune system. They can lyse target cells and secrete immunoregulatory cytokines early during immune responses. They mediate protection against viruses and tumours, and can reject MHC class I mismatched bone marrow grafts. LÄS MER